Removal Versus Retention of Cerclage in Preterm Premature Rupture of Membranes (PPROM) (PROMCerclage)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine whether retention of cervical cerclage after PPROM improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
| Condition | Intervention | Phase |
|---|---|---|
|
Fetal Membranes, Premature Rupture |
Procedure: Retention of Cerclage Procedure: Removal of Cerclage Procedure: Removal vs. Retention of Cervical Cerclage |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Removal Versus Retention of Cervical Cerclage in Preterm Premature Rupture of Membranes-A Multicenter Randomized Clinical Trial |
- Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness [ Time Frame: conception to birth ] [ Designated as safety issue: Yes ]
- Composite neonatal outcome - any one of the following (for twins, either infant): Fetal or neonatal death [ Time Frame: Birth to 28days of life ] [ Designated as safety issue: Yes ]
- Respiratory distress syndrome [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
- Documented sepsis within 72 hours of delivery [ Time Frame: birth to 72 hours after delivery ] [ Designated as safety issue: Yes ]
- Grade 3 or 4 intraventricular hemorrhage [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
- Stage 2 or 3 necrotizing enterocolitis [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
- Neonatal intensive care unit (NICU) stay [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
- Birth weight [ Time Frame: at birth ] [ Designated as safety issue: Yes ]
- Estimated gestational age (EGA) at delivery [ Time Frame: at delivery ] [ Designated as safety issue: Yes ]
- Postpartum endometritis [ Time Frame: birth to 28days of life ] [ Designated as safety issue: Yes ]
- Maternal sepsis [ Time Frame: birth to 28days following delivery ] [ Designated as safety issue: Yes ]
- Latency [ Time Frame: labor to delivery ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 142 |
| Study Start Date: | November 2004 |
| Estimated Study Completion Date: | November 2014 |
| Estimated Primary Completion Date: | September 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1 Retention of Cerclage
Group one = Subject whose Cerclage is retained after randomization.
|
Procedure: Retention of Cerclage
Retain Cerclage until clinical removal is indicated by protocol
Procedure: Removal vs. Retention of Cervical Cerclage
Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress
Other Name: McDonald or Shirodkar Cerclage
|
|
Active Comparator: 2 - Removal of Cerclage
Group 2 = Subjects who will have cerclage removed after randomization
|
Procedure: Removal of Cerclage
Immediate removal of Cerclage following randomization
Procedure: Removal vs. Retention of Cervical Cerclage
Immediate removal of cerclage following randomization vs. retention of cerclage until labor, chorioamnionitis, or fetal distress
Other Name: McDonald or Shirodkar Cerclage
|
Detailed Description:
The placement of cervical cerclage is standard of care for women who experience incompetent cervix. Treadwell et al, published the largest retrospective review of 482 patients receiving cerclage (364 elective and 118 emergent). They found premature rupture of membranes (PROM) in 38% of the subjects with 9% delivering <27 weeks. Preterm birth is the cause of at least 75% of neonatal deaths that are not due to congenital malformations. The question of whether to remove cerclage after preterm premature rupture of membranes (PPROM) is one of the unresolved controversies in obstetrics because the few available studies are retrospective, all have small numbers of patients, and the studies have given conflicting results regarding the safety of retaining a cerclage after preterm premature rupture of the membranes. It is unclear from the retrospective studies whether latency (the interval from membrane rupture to the onset of labor) is prolonged with retention of the suture. Furthermore, some, but not all studies suggest an increase in major infectious maternal morbidity and possibly neonatal morbidity. For this reason, clinicians vary greatly in deciding on whether to remove a cerclage in a patient with PPROM and either practice is currently an acceptable standard. This is a fairly rare complication, the combination of PPROM in a patient with cerclage in place only occurs in about 1-3/1000 pregnant women. Thus it has been impossible to study this problem prospectively in any single institution. The establishment of the Obstetrix Collaborative Research Group affords the unique opportunity to study this rare complication. Obstetrix manages 19 practices of Perinatologists around the U.S. and Mexico and is comprised of nearly 100 such subspecialists. This problem is most often referred to a Perinatologist when it occurs, so it is not unusual for these practices to see 5 - 10 such patients per year. Obstetrix fully funds the infrastructure of this research group and inclusion in this study will not alter the cost of patient care in either group as there is virtually no cost in removing the cerclage and all these patients are kept in hospital until delivery when membranes rupture as standard of care.
This is a multicenter trial. The purpose is to determine whether retention of cerclage after preterm premature rupture of the membranes improves latency (without a significant increase in chorioamnionitis) and lessens neonatal morbidity.
Eligibility| Ages Eligible for Study: | 18 Years to 60 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- A previously placed prophylactic cerclage defined as any cerclage done < 23 6/7 weeks including those done for previous history of cervical incompetence, asymptomatic cervical shortening (regardless of effacement) and asymptomatic cervical dilation < 3 cm
- Spontaneous rupture of membranes 22-32 weeks
- Singleton or twin gestation
- Shirodkar or McDonald cerclage in place > 1 week
Exclusion Criteria:
- Active labor (> 8 uterine contractions [UCs] per hour)
- Chorioamnionitis as defined by temperature > 38 plus fetal tachycardia or uterine tenderness
- Placenta previa or undiagnosed vaginal bleeding
- Nonreassuring fetal status by nonstress test (NST) or biophysical profile (BPP)
- Mature pulmonary studies
- Positive gram stain, culture, white blood cells (WBC) > 30, or glucose < 14 on amniocentesis
- Major fetal anomaly
- Presentation > 48 hours after rupture of membranes
- abdominal cerclage
- Cerclage done for symptomatic cervical dilation (cervix dilated > 3 cm)
- Post amniocentesis membrane rupture (rupture which occurs within one week of amniocentesis)
Contacts and Locations| Contact: Kimberly Maurel, MSN | 714-593-9171 | kimberly_maurel@pediatrix.com |
| Contact: Diana Abril, MS CRM | 480-659-8644 | diana_abril@pediatrix.com |
Hide Study Locations| United States, Alabama | |
| University of South Alabama Medical Center | Withdrawn |
| Mobile, Alabama, United States, 36617 | |
| United States, Arizona | |
| Desert Good Samaritan Hospital | Recruiting |
| Mesa, Arizona, United States, 85202 | |
| Contact: Shirley Sawai, MD 602-239-2647 shirley_sawai@pediatrix.com | |
| Contact: Ana Braescu, RN, MSN 602-239-3632 office Ana_braescu@pediatrix.com | |
| Principal Investigator: Shirley Sawai, MD | |
| Banner Good Samaritan Hospital | Recruiting |
| Phoenix, Arizona, United States, 85006 | |
| Contact: Shirley Sawai, MD 602-239-2647 shirley_Sawai@pediatrix.com | |
| Contact: Ana Braescu, RN, MSN 602-239-3632 ana_braescu@pediatrix.com | |
| Principal Investigator: Shirley Sawai, MD | |
| Tucson Medical Center | Recruiting |
| Tucson, Arizona, United States, 85712 | |
| Contact: Miller Hugh, MD 520-795-8188 hmiller@ahsc.arizona.edu | |
| Contact: Diane Mercer, RN 520-881-9662 | |
| Principal Investigator: Hugh Miller, MD | |
| United States, California | |
| Saddleback Memorial Medical Center | Terminated |
| Laguna Hills, California, United States, 92653 | |
| Long Beach Memorial Medical Center | Recruiting |
| Long Beach, California, United States, 90801-1428 | |
| Contact: Michael Nageotte, MD 562-933-2730 Michael_nageotte@pediatrix.com | |
| Contact: Christine Preslicka, RN 562-933-2730 CPreslicka@memorialcare.org | |
| Principal Investigator: Michael Nageotte, MD | |
| University of Southern California-Irvine Medical Center | Terminated |
| Orange, California, United States, 92868 | |
| Good Samaritan Hospital | Recruiting |
| San Jose, California, United States, 95124 | |
| Contact: Andrew Combs, MD 408-371-7111 andrew_combs@pediatrix.com | |
| Contact: Kimberly Mallory, RN 408-559-2327 kimberly_mallory@pediatrix.com | |
| Principal Investigator: Andrew Combs, MD | |
| Santa Clara Valley Medical Center | Withdrawn |
| San Jose, California, United States, 95128 | |
| United States, Colorado | |
| Presbyterian/St Luke's Hospital | Terminated |
| Denver, Colorado, United States, 80218 | |
| Rose Medical Center | Terminated |
| Denver, Colorado, United States, 80220 | |
| Swedish Medical Center | Terminated |
| Denver, Colorado, United States, 80110 | |
| University of Colorado Hospital | Withdrawn |
| Denver, Colorado, United States, 80262 | |
| United States, Connecticut | |
| Yale New-Haven Medical Center | Terminated |
| New Haven, Connecticut, United States, 06504 | |
| United States, Georgia | |
| Memorial Health University Medical Center | Withdrawn |
| Savannah, Georgia, United States, 31404 | |
| United States, Illinois | |
| University of Illinois at Chicago | Terminated |
| Chicago, Illinois, United States, 60612 | |
| United States, Louisiana | |
| Lousiana State University Health Science | Terminated |
| Shreveport, Louisiana, United States, 60612 | |
| United States, Michigan | |
| Hutzel Women's Hospital | Recruiting |
| Detroit, Michigan, United States, 48201 | |
| Contact: Shobha Mehta, MD 313-745-0499 smehta@med.wayne.edu | |
| Principal Investigator: Shobha Mehta, MD | |
| United States, Missouri | |
| Saint Luke's Hospital, Kansas City | Recruiting |
| Kansas City, Missouri, United States, 64111 | |
| Contact: George Lu 816-932-6903 glu@saint-lukes.org | |
| Principal Investigator: George Lu, MD | |
| Mercy Hospital of St. Louis | Not yet recruiting |
| St. Louis, Missouri, United States, 63141 | |
| Contact: Bruce Morris, MD 314-991-5000 bmorrismfm@gmail.com | |
| Contact: Nancy Bubenik, NP 314-991-5000 nancy_bubenik@pediatrix.com | |
| Principal Investigator: Bruce Morris, MD | |
| United States, Nevada | |
| Sunrise Medical Center | Recruiting |
| Las Vegas, Nevada, United States, 89109 | |
| Contact: Brian Iriye, MD 702-382-3200 ext 1 biriye@mfmcenter.com | |
| Principal Investigator: Brian Iriye, MD | |
| Summerlin Hospital | Withdrawn |
| Las Vegas, Nevada, United States, 89106 | |
| United States, New York | |
| University of Rochester Medical Center | Recruiting |
| Rochester, New York, United States, 14642 | |
| Contact: Tulin Ozcan, MD 585-275-7824 tulinozcan27@hotmail.com | |
| Principal Investigator: Tulin Ozcan, MD | |
| United States, Ohio | |
| The University Hospital | Terminated |
| Cincinnati, Ohio, United States, 45219 | |
| United States, Oregon | |
| Sacred Heart Medical Center | Terminated |
| Eugene, Oregon, United States, 97401 | |
| United States, Tennessee | |
| Erlanger Medical Center | Recruiting |
| Chattanooga, Tennessee, United States, 37403 | |
| Contact: David Adair, MD 423-664-4460 | |
| Contact: Lorrie Mason, RN 423-664-4460 lorrie@rocob.com | |
| Principal Investigator: David Adair, MD | |
| United States, Texas | |
| Memorial Hermann Children's Hospital-Texas Center for Fetal Assessment | Recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Ramirez Mildred, MD 713-500-6423 | |
| Principal Investigator: Mildred Ramirez, MD | |
| United States, Utah | |
| University of Utah Health Sciences Center | Withdrawn |
| Salt Lake City, Utah, United States, 84132 | |
| United States, Washington | |
| Evergreen Hospital | Terminated |
| Kirkland, Washington, United States, 98034 | |
| Swedish Medical Center | Recruiting |
| Seattle, Washington, United States, 98122-4307 | |
| Contact: David Luthy, MD 206-386-2101 david_luthy@pediatrix.com | |
| Contact: Tina Lopez, RN 206-215-3541 tina_lopez@pediatrix.com | |
| Principal Investigator: David Luthy, MD | |
| Sub-Investigator: David Gorenberg, MD | |
| Study Director: | Kimberly Maurel, RN, MSN, CNS | Obstetrix Medical Group, Inc. |
More Information
Additional Information:
Publications:
| Responsible Party: | Obstetrix Medical Group |
| ClinicalTrials.gov Identifier: | NCT00201656 History of Changes |
| Other Study ID Numbers: | OBX0002, OBX0002 |
| Study First Received: | September 13, 2005 |
| Last Updated: | January 2, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Obstetrix Medical Group:
|
PPROM Cerclage Preterm Premature Rupture of the Membranes with Cerclage |
Additional relevant MeSH terms:
|
Fetal Membranes, Premature Rupture Rupture Obstetric Labor Complications Pregnancy Complications Wounds and Injuries |
ClinicalTrials.gov processed this record on May 23, 2013